Concepedia

Murielle Roussel

MR

80

Publications

8.7K

Citations

40

H-Index

2000

Active since

Affiliations

Sorbonne Université(Current)

Hôpital Saint-Antoine

Institut universitaire du cancer de Toulouse Oncopole

Hôpital Claude Huriez

Institut Paoli-Calmettes

Murielle Roussel is an author at Sorbonne Université specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2000–2025

80

Publications

80

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit et al. · New England Journal of Medicine · 2012 · 1.1K citations · Full text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 922 citations · Full text

, , +9

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

Jean‐Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret et al. · Blood · 2008 · 567 citations · Full text

Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)

Hervé Avet‐Loiseau, Xavier Leleu, Murielle Roussel et al. · Journal of Clinical Oncology · 2010 · 419 citations · Full text

Rows per page

1–5 of 80